SIREN: 953178928
SIRET: 95317892800016
Nigel Cryer is a pragmatic leader and strategist able to investigate complex issues, train people, write procedures and yet present winning strategies for growth, FDA inspections and operational/organizational excellence.
The vision for Bluciela is to enable patient centric solutions by focussing on the critical.
Having worked in the industry for more than 30 years, Nigel knows many of the best people in the industry.
His passion is to deliver high quality medicines in a pragmatic & effective manner
Corporate Social Responsibility Action Completed
My experience in Africa and knowledge of distribution of medicines has made me dedicated to deliver improvements. I issued a report to the Kenyan MOH and this was fully accepted and he wanted to implement across Kenya. Civeli war distrupted this plan. Today the same issues are in place: 36km walk to the nearest dispensary. Only one person managing and if they are not there another 36km or a long wait. Each dispensary has only 50% of essential medicines and they are replenished at best once per year and often less becuase there is no mapping of the dispensaries.
I contacted WHO about the poor quality of vaccines often frozen and destroyed. I raised the funding from DHL Lifesciences and together with WHO and the university of Warsaw we validated the shake test,
Strategic pharmaceutical & biotech executive - building Global, Regional and Local systems and strategies with more than 30 years in Pharma/bio-tech with AstraZeneca, Merck&Co, Roche, Watson, J&J, Sanofi, Sanofi Vaccines, Norgine, NextPharma & DHL Deutsche Post. Involved in hosting inspections globally with top tier inspectorates. Updating & building systems for all manufacturing & GxP activities. 100% successful in all audit readiness and recovery programs including FDA, MHRA, ANSM, BfArM Swiss Medic, Anvisa etc A passionate, energetic, pragmatic leader, always wearing a smile, who focusses on the critical and is extremely calm under extreme pressure. Nigel has built an extremely large network of experts with whom he has managed or worked alongside.
Nigel was the conference chairman for all the PDA conferences to launch the new guidance for API cGMP ICH Q7a with all other speakers representing regulatory agencies eg. MHRA, FDA, ANSM, B.Farm, Swiss Medic, MEB (NL) etc.
Nigel was the Chairman of APIC Cefic leading a large group of EU API manufactures and developing guidence.
Nigel was a lead speaker at the launch of the ISPE Risk based Commissioning & Qualification roll out and implementation meetings. Nigel implemented and a risk based approach in 1998 and was inspected by MHRA and FDA.
Nigel has spoken at conferences on Risk based Pharmacovigilance, Regulatory compliance, Inspection readiness, validation, cleaning validation, Computer system validation & Digital system, Design Data Integrity, QC management, cold chain management, Logistics, clinical trials and many more.
Bluciela-Lifesciences has 3 CSR projects
1
Availability of Essential Medicines:
Making 100% of essential medicines available locally in developing nations.
2
Females in Developing Nations : Providing a better chance of a career
Enabling girls to remain in the education system. Universities have a 50:50 gender split not 90% males as it is now. Often females are married at a young age and stop attending school at age 11 to 13.
3
Detecting Frozen Vaccines:
Ensuring that vaccines are delivered in the best condition to the patient. Many have been frozen & only detectable by use of the shake test. Introducing a VVM - Vaccine vial monitor would enable immediate detection of frozen vaccines.
Nadia Cryer – will lead Corporate social responsibility, property management, sales/marketing& customer liason has qualifications in business management speaks 7 languages including: English, French, German (Including Swiss German), Arabic (Including 5 arabic dialects), Spanish, Italian, Maltese